Today, we introduce you to MYOS President and Chief Operating Officer Peter Levy. Levy, who comes to MYOS Corporation with an impressive career as a practicing attorney, CPA firm partner, SEC integrity monitor and CEO of another publicly traded company, says the key reason he wanted to join the MYOS team is because of founder Dr. Robert Hariri. “Bob’s vision for MYOS, both in terms
MYOS Executive Chairman Robert Hariri, MD, PhD Responds to WSJ Article: “Drugs Aim to Help Elderly Rebuild Muscle”
The Wall Street Journal this morning released an article touting the significant developments being made in the field of myostatin inhibitors and muscle health research. MYOS Corporation, a bionutrition and biotherapeutics company, is a key player in the field of muscle health. In addition to focusing on the development and commercialization of products that improve the muscle function
Rather than retrofit existing regulations, perhaps it’s time to start fresh, taking into account emerging science on muscle performance and it’s impact on healthy aging. There are many studies that show skeletal muscle strength is a good indication of overall health and well-being. Evidence of a product or activity that increases muscle strength is also pretty straightforward.
MYOS Corporation board member and independent director Peter Diamandis, MD, was recently named one of the world’s top 50 greatest leaders by Fortune Magazine. Diamandis, who joined MYOS in 2011, is also Chairman and CEO of X PRIZE Foundation, a non-profit organization that creates large-scale incentivized prize competitions that lead to global innovations to benefit humanity.
Follow MYOS on Facebook, Twitter, Google+ and LinkedIn to Raise Money for the Muscular Dystrophy Association (MDA)! This Sunday, March 23rd, MYOS will participate in the New Jersey MDA Muscle Walk fundraising event at the Prudential Center in Newark, NJ. MYOS employees, affiliates and their families have teamed up to pay tribute to children and adults served by the Muscular
As thousands joined the fight over the past few weeks to save Josh Hardy’s life by lobbying drug company Chimerix to allow the dying boy access to its potentially life-saving treatment, supporters finally received the news they’d been hoping for on Tuesday evening. In a statement late in the day, Chimerix CEO Kenneth I. Moch confirmed that the FDA had approved an
The recent founding of Human Longevity Inc. combined with the groundbreaking work of MYOS could hold the key to longer lifespans. MYOS Corporation founder Robert Hariri, MD, PhD announced last week the formation of Human Longevity Inc. (HLI), a new company co-founded by Hariri, Peter H. Diamandis, MD and J. Craig Venter, PhD. The new genomics and cell